Abstract: The invention concerns the use of antithrombin III with a modified conformation which is referred to as activated antithrombin III (IDAAT=immune defence activated antithrombin) as a medicament.
Type:
Grant
Filed:
September 12, 2001
Date of Patent:
June 17, 2008
Assignee:
Hamburger Stiftung zur Förderung von Wissenschaft und Kultur c/o MERA GmbH